Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal

Nigel Armstrong, Manuela Joore, Thea van Asselt, Kate Misso, Nathan Manning, Florian Tomini, Jos Kleijnen, Rob Riemsma

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)415-425
JournalPharmacoeconomics
Volume31
Issue number5
DOIs
Publication statusPublished - 2013

Cite this

Armstrong, Nigel ; Joore, Manuela ; van Asselt, Thea ; Misso, Kate ; Manning, Nathan ; Tomini, Florian ; Kleijnen, Jos ; Riemsma, Rob. / Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal. In: Pharmacoeconomics. 2013 ; Vol. 31, No. 5. pp. 415-425.
@article{7ca3b0fb5a4643f08a1c108f859e980e,
title = "Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal",
author = "Nigel Armstrong and Manuela Joore and {van Asselt}, Thea and Kate Misso and Nathan Manning and Florian Tomini and Jos Kleijnen and Rob Riemsma",
year = "2013",
doi = "10.1007/s40273-013-0049-2",
language = "English",
volume = "31",
pages = "415--425",
journal = "Pharmacoeconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "5",

}

Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal. / Armstrong, Nigel; Joore, Manuela; van Asselt, Thea; Misso, Kate; Manning, Nathan; Tomini, Florian; Kleijnen, Jos; Riemsma, Rob.

In: Pharmacoeconomics, Vol. 31, No. 5, 2013, p. 415-425.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal

AU - Armstrong, Nigel

AU - Joore, Manuela

AU - van Asselt, Thea

AU - Misso, Kate

AU - Manning, Nathan

AU - Tomini, Florian

AU - Kleijnen, Jos

AU - Riemsma, Rob

PY - 2013

Y1 - 2013

U2 - 10.1007/s40273-013-0049-2

DO - 10.1007/s40273-013-0049-2

M3 - Article

C2 - 23580355

VL - 31

SP - 415

EP - 425

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 5

ER -